Johnson & Johnson said Friday it was preparing to resume the clinical trial of its experimental vaccine to fight COVID-19, which was suspended last week after a volunteer fell ill.
Johnson & Johnson will resume its COVID vaccine trial in the US. J&J said it is "planning to resume recruitment" for the phase 3 trial, which began in Sept & should ultimately have 60k participants. The trial was suspended when a volunteer got sick medicalxpress.com/news/2020-10-j…pic.twitter.com/zPEX7CiKsY